Edoardo Cignoli : Setback for Novartis Heart Drug

The Swiss drug maker said it will ask the European health regulator to re-examine its acute heart-failure drug serelaxin after it received a negative opinion.



via WSJ.com: US Business http://ift.tt/1eJhs2Q